Cancer that starts in the lymph nodes is called lymphoma. It develops from lymphocytes, the white blood cells that normally live in your lymph nodes and help fight infections. But not all cancer found in lymph nodes is lymphoma. When cancer from another part of the body, like the breast or lung, spreads to nearby lymph nodes, it’s called metastatic cancer and is still named after the organ where it originated.
Lymphoma: Cancer That Starts in Lymph Nodes
Lymphoma is the blanket term for cancers that begin in the lymphatic system. Because lymphocytes travel throughout the body via a network of lymph vessels and nodes, lymphoma can develop in lymph nodes almost anywhere: the neck, armpits, chest, abdomen, or groin. It splits into two major categories based on what the cancer cells look like under a microscope.
Hodgkin lymphoma is identified by the presence of a distinctive abnormal cell called a Reed-Sternberg cell. It typically arises from B lymphocytes, one of the main types of immune cells. Hodgkin lymphoma is less common overall but tends to follow a more predictable pattern of spread, often moving from one group of lymph nodes to the next.
Non-Hodgkin lymphoma is far more common and encompasses dozens of subtypes. It can develop from B lymphocytes, T lymphocytes, or natural killer cells. Because it covers so many different diseases, non-Hodgkin lymphoma varies widely in how aggressive it is. Some forms grow slowly over years, while others require immediate treatment. An estimated 79,320 new cases of non-Hodgkin lymphoma are expected in the United States in 2026 alone, with a five-year survival rate of about 74%.
When Cancer Spreads to Lymph Nodes From Elsewhere
Finding cancer in a lymph node doesn’t automatically mean you have lymphoma. In many cases, cancer cells from a tumor in another organ have traveled through the lymphatic system and lodged in a nearby node. This is metastatic disease. If breast cancer spreads to the underarm lymph nodes, for example, it’s still breast cancer, not lymphoma. The cells look and behave like breast cancer cells, and treatment targets that original cancer type.
Cancer cells that reach the lymph nodes appear to actively reshape the immune environment there. Research from the National Cancer Institute found that melanoma cells that spread to lymph nodes carried higher levels of proteins that tell immune cells to stand down. The result: cancer-killing immune cells became less effective, while regulatory immune cells that suppress the body’s defenses increased in number. In animal studies, those regulatory cells actually helped cancer spread further to distant organs like the lungs. This is one reason doctors pay close attention to whether cancer has reached the lymph nodes when determining how advanced a disease is.
Doctors classify the extent of spread in lymph nodes by size. Clusters of cancer cells measuring 0.2 mm or smaller (roughly 200 cells) are classified as isolated tumor cells. Slightly larger deposits are called micrometastases, and anything beyond that is a macrometastasis. These distinctions matter because they influence staging and treatment decisions.
Symptoms That Distinguish Cancerous Lymph Nodes
Swollen lymph nodes are extremely common and usually mean your immune system is fighting an infection. The challenge is telling the difference between a reactive node and a potentially cancerous one. Several features raise the level of concern: nodes that feel hard or firm rather than soft, nodes that are fixed in place rather than movable under the skin, swelling that lasts longer than two weeks, and nodes located above the collarbone (a supraclavicular location is particularly suspicious).
Age also matters. Malignant causes of lymph node swelling are rare in children and become progressively more likely with age. On the other hand, swelling that has been stable for over a year without growing is very unlikely to be cancer. As a general guideline, unexplained swollen lymph nodes that persist beyond a month without an obvious cause like an infection typically warrant further evaluation.
Lymphoma specifically can cause painless swelling in the neck, armpit, or groin along with systemic symptoms: unexplained fevers, drenching night sweats, and unintentional weight loss. These are sometimes called “B symptoms” and can help distinguish lymphoma from a simple infection.
How Lymph Node Cancer Is Diagnosed
A biopsy is the only way to confirm whether cancer is present in a lymph node. There are several approaches, and the choice depends on where the node is and what doctors suspect.
- Fine-needle aspiration uses a thin needle to draw out fluid and cells from a node that can be reached through the skin. It’s quick and minimally invasive but collects a small sample.
- Core needle biopsy uses a slightly larger needle to extract a small cylinder of intact tissue, giving pathologists more to work with.
- Sentinel node biopsy targets the first lymph nodes that drain from a known tumor. If cancer hasn’t reached the sentinel node, it’s unlikely to have spread further into the lymphatic system.
- Open (excisional or incisional) biopsy involves a surgical incision to remove all or part of a lymph node. This is often preferred when lymphoma is suspected, because pathologists need the node’s architecture intact to identify the specific subtype.
How Staging Differs for Lymphoma vs. Metastatic Disease
Lymphoma and metastatic cancers in the lymph nodes are staged using entirely different systems. Lymphoma is traditionally staged with the Ann Arbor system (updated as the Lugano classification), which tracks how many groups of lymph nodes are involved and whether the disease has spread above or below the diaphragm or into organs outside the lymphatic system. Stage I means a single lymph node region is affected, while stage IV indicates widespread disease.
When cancer from a solid tumor spreads to nearby lymph nodes, staging uses the TNM system. The “N” in TNM specifically describes how many lymph nodes contain cancer and how close they are to the original tumor. A higher N number generally signals more advanced disease and influences what treatment options are recommended. The distinction between these two staging approaches reflects the fundamental difference: lymphoma is a disease of the lymph nodes themselves, while metastatic involvement means the lymph nodes are a secondary site.